Clinical Trials Browser

Lymphoma, Follicular, Waldenstrom Macroglobulinemia, Recurrence, Lymphoma, Large B-Cell, Diffuse, Lymphoma, B-Cell, Marginal Zone, Hematologic Neoplasms, Lymphoma, Mantle-Cell

Clinical Trials

A Study of Patient Characteristics, Co-Morbidities, and Treatment Patterns in Chronic Myeloid Leukemia Patients in Kuwait

A Study of BL-M11D1 in Combination With Cytarabine + Daunorubicin or Venetoclax + Azacitidine in Patients With Acute Myeloid Leukemia

AUDAX

A Study of APG-3288 in Relapsed/Refractory Blood Cancers

A Study of Pirtobrutinib (LY3527727) in Participants With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Safety and Efficacy of Asciminib in Pediatrics and Young Adults With Relapse/Refractory (r/r) Philadelphia Positive (Ph+) or ABL-class Ph-like Acute Lymphoblastic Leukemia (ALL)

MAVRiC

LATITUDE

A Study to Assess Adverse Events and How Intravenous (IV) Pivekimab Sunirine Moves Through the Body in Pediatric Participants With Relapsed or Refractory Acute Myeloid Leukemia (AML)

A Phase 1b Study of Lonitoclax + Azacitidine in Acute Myeloid Leukemia Patients

A Phase I Trial of QLS2313 Injection in Relapsed/Refractory Hematological Malignancies

A Long-term Follow-up Study of Patients With ARD103 CAR-T Cell Therapies

HAPLO2022

A Study of BL-M24D1 in Patients With Relapsed or Refractory Multiple Myeloma and Other Hematologic Malignancies

A Phase Ib Study of the Selective PKC-β Inhibitor MS-553 in Patients With Refractory or Relapsed CLL/SLL

RESOLVE AML001

A Clinical Study of BT02 in Patients With Relapsed or Refractory Hematologic Malignancies

HPB-092 for the Treatment of Relapsed and Refractory Acute Myeloid Leukemia

γδ T Cell Therapy for Relapse Prevention in High-Risk AML Post-Transplant

Safety and Proof-of-Concept Study of RPT1G in Adults With Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndromes

An Open-label, Dose-Escalation and Dose-Expansion Study of GB3226 in Patients With Relapsed/Refractory Acute Myeloid Leukemia

A Phase I Clinical Trial of RS001 in Patients with Relapsed/Refractory B-Cell Malignancies

iNK-r/r AML

A Clinical Trial to Evaluate the Safety and Tolerability of TQB3911 Tablets in Patients With BCR::ABL Fusion Gene Positive Leukemia

Clinical Research of CD19 Targeted CAR-T Cell in Relapsed/ Refractory B-ALL

Study of HS-10382 Combination in Patients With Chronic Myeloid Leukemia (CML)

ACHIEVE2

A Trial to Evaluate the Safety and Efficacy of NCR300 in Preventing Recurrence of Acute Myeloid Leukemia（AML) After Transplantation

A Study of AK117 in Combination With Azactidine Plus Venetoclax in Patients With Acute Myeloid Leukemia

Clinical Trial of ssCART-19 Cell Injection in the Treatment of Relapsed or Refractory Acute Lymphoblastic Leukemia (Including Central Nervous System Infiltration)

BG1805 Injection in the Treatment of Relapsed or Refractory Acute Myeloid Leukemia in Children

Anti-GPRC5D CAR-T Cells (CT071) in Participants With RRMM or RRpPCL

A Bridging Study of Liposomal Cytarabine-Daunorubicin in Treating Olderly Patients With Treatment-naive High-Risk (Secondary) Acute Myeloid Leukemia

Determining Clinical Study Experiences of Chronic Lymphocytic Leukemia Patients

Assessing Medical Trial Experiences of Hairy Cell Leukemia Patients

Safety and Efficacy Evaluation of Next-generation CD19-UCART

A Study to Evaluate the Safety and Tolerance of SYHX1903 in Patients With Relapsed/Refractory Hematologic Malignancies